ARCHIVES

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

This article is from The Cancer Letter archive.

Vol. 08 No. 26 | June 25, 1982

Download PDF Visit The Full Archive

Related Articles

Final stats On FY92 Budget; Success Rate Was 35 Percent

December 4, 1992

RFA: Long-Term Cancer Survivors

September 12, 1997

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

Executive Summary of Centers, SPOREs Report

February 28, 2003

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014